Drugs by condition
Drugs approved for influenza
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
8
Still marketed, NDA or BLA
Drug classes
2
Novel drugs
4
New molecular entities and new biologics
In development
24
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for influenza.
- Xofluza (Baloxavir Marboxil) · Genentech INC Aug 11, 2022
- Xofluza (Baloxavir Marboxil) · Genentech INC NovelPriority reviewOct 24, 2018
- Vigamox (Moxifloxacin Hydrochloride) · Harrow Eye Apr 15, 2003
- Tamiflu (Oseltamivir Phosphate) · Roche Priority reviewDec 14, 2000
- Tamiflu (Oseltamivir Phosphate) · Roche NovelPriority reviewOct 27, 1999
All approved drugs for influenza, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 69 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Neuraminidase Inhibitor (1)
- Relenza Zanamivir · Glaxosmithkline · 1999
Class not listed in FDA's data (7)
- Xofluza Baloxavir Marboxil · Genentech INC · 2018
- Tamiflu Oseltamivir Phosphate · Roche · 1999
- Cefotan Cefotetan Disodium · Pai Holdings Pharm · 1985
- Xofluza Baloxavir Marboxil · Genentech INC · 2022
- Vigamox Moxifloxacin Hydrochloride · Harrow Eye · 2003
- Tamiflu Oseltamivir Phosphate · Roche · 2000
- Eryped Erythromycin Ethylsuccinate · Carnegie · 1965
Drugs in development for influenza
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- Investigational Influenza VaccinePhase 34 trials
BioNTech SE · Influenza, COVID-19, COVID-19 (Coronavirus Disease 2019)
- GP681Phase 32 trials
Jiangxi Qingfeng Pharmaceutical Co. Ltd. · Influenza, Human, Influenza
- GP681 SimulantPhase 32 trials
Jiangxi Qingfeng Pharmaceutical Co. Ltd. · Influenza, Human, Influenza
- IIV-HDstandalonePhase 32 trials
Sanofi · COVID-19 Immunization, Influenza Immunization, Immunization
- Inactivated Polio vaccinePhase 32 trials
LG Chem · Diphtheria, Tetanus, Pertussis
- ZSP1273Phase 32 trials
Guangdong Raynovent Biotech Co., Ltd · Influenza A, Influenza a
- ADC189Phase 31 trial
Jiaxing AnDiCon Biotech Co.,Ltd · Influenza Type A, Influenza Type B
- BK1803Phase 31 trial
Tanabe Pharma Corporation · Pertussis, Diphtheria, Tetanus
- BRC-201TG-1000, Pixavir MarboxilPhase 31 trial
Boryung Biopharma Co., Ltd. · Influenza
- mRNA-1018-H5Phase 31 trial
Moderna · Influenza
- NVXC19EU licensed, standalonePhase 31 trial
Sanofi · Immunization, Healthy Volunteers, COVID-19 Immunization
- Flu mRNAGSK6479720A, GSK6498032APhase 22 trials
GSK · Influenza, Human
- Fluzone QudrivalentPhase 22 trials
Sanofi · Healthy Volunteers, Influenza Immunization, Influenza
- rC19Novavax's adjuvanted recombinant COVID-19Phase 22 trials
Sanofi · COVID-19 Immunization, Influenza Immunization
- TRX-100Phase 22 trials
Traws Pharma, Inc. · Influenza
- ApomivirFE-L-APO, drug substancePhase 21 trial
Far East Bio-Tec Co., Ltd · Influenza
- ARCT-2304Phase 21 trial
Arcturus Therapeutics, Inc. · Influenza, Human
- AZD4117Phase 21 trial
AstraZeneca · Influenza A
- AZD5315Phase 21 trial
AstraZeneca · Influenza A
- DL001ZF2G22B, F2H23HPhase 21 trial
GSK · Influenza, Human
More on influenza: recruiting trials · published research
Related in infectious disease and vaccines: HIV · Hepatitis B · Hepatitis C · COVID-19 · RSV · Urinary tract infection · Pneumonia · Skin infections · C. difficile infection · Fungal infections
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.